Related by context. All words. (Click for frequent words.) 75 catheter occlusion 69 acute peripheral arterial 68 occlusion PAO 67 EnteroMedics proprietary neuroblocking technology 67 Combo Stent 66 vitreoretinal disorders 66 acetonide FA 66 GEM OS2 66 CYT# potent vascular disrupting 66 MKC# MKC# PP 65 Perforomist ™ Inhalation Solution 65 Resten NG 65 Pivotal Trial 64 Alfimeprase 64 Augment TM 64 Initiates Phase II 64 TLK# 64 Microplasmin 64 phase IIb clinical 64 aldehyde dehydrogenase ALDH2 deficiency 64 TELINTRA 64 XL# anticancer compounds 64 Personalized Immunotherapy 64 delivers fluocinolone acetonide FA 64 R Saizen R 64 vapreotide acetate 64 modified glutathione analog 64 Serostim ® 64 Zemiva ™ 63 Novel Oral 63 LymphoStat B TM 63 TKB# 63 molecular imaging radiopharmaceutical 63 including eniluracil ADH 63 NAVISTAR R 63 Xanafide 63 kidney urologic 63 targeted radiotherapeutic 63 DURECT proprietary 63 prokinetic agent 63 vagal blocking therapy 63 novel nucleoside analog 63 hypoxia activated prodrug 63 VBLOC TM 63 either acutely decompensated 63 topically applied SEPA 63 tiapamil 63 Solazed ™ 63 multicenter Phase III 63 ABL inhibitor 63 oral prodrug 63 SinuNase TM 63 acyclovir Lauriad R 63 docetaxel Taxotere ® 63 mGluR5 negative 63 Elagolix 63 sodium thiosulfate STS 63 Phase #b/#a clinical 63 liposomal formulation 63 metaglidasen 63 Meets Primary Endpoint 63 ALVESCO R 63 oral picoplatin 62 AERx R 62 Phase III confirmatory 62 TRANSDUR ™ 62 thrombolytic agent 62 Aurexis 62 myelofibrosis polycythemia vera 62 Initiates Enrollment 62 XP# XP# 62 Ascendra 62 VBLOC ™ 62 Completes Enrollment 62 peripherally acting 62 serologically active systemic lupus 62 recurrent metastatic ovarian cancer 62 TM Drug Eluting 62 ALVESCO ® 62 Glufosfamide 62 TBC# 62 FUSILEV ® 62 lintuzumab SGN 62 reslizumab 62 Frozen Shoulder syndrome Adhesive 62 candidates Azedra TM 62 stent DES 62 BENLYSTA ® 62 NP2 Enkephalin 62 XL# XL# XL# 62 FOLOTYN ® 62 Hsp# Inhibitor 62 EP #R 62 MKC# MT 62 external counterpulsation systems 62 HGS ETR1 mapatumumab 62 TRANSDUR ® 62 PI3K/Akt pathway inhibitor 62 Phase Ib clinical trials 62 ELADUR TM 62 LEUKINE 62 constipation OIC 62 product platforms AZX# 62 volociximab 62 treat chronic sinusitis 62 ribavirin Copegus ® 62 Dacogen injection 62 oral proteasome inhibitor 62 Solazed TM 62 Endologix Powerlink System 62 lexidronam injection 62 Combination REOLYSIN R 62 orally inhaled migraine 62 Pafuramidine 62 delivery polymer matrix 62 Cannabinor 62 Pivotal Clinical Trial 62 orally administered inhibitor 62 Azedra 62 treating abdominal aortic 62 Phase III Clinical Trial 62 alvespimycin 62 Eculizumab 62 Phase IIb Trial 62 personalized cellular immunotherapy 62 Albuferon TM 61 brand ciclesonide HFA 61 BRIM2 61 novel VDA molecule 61 erythematosus SLE 61 Initiates Clinical Trial 61 dyskinesia PD LID 61 Archexin 61 generation purine nucleoside 61 ELADUR ™ 61 ALN PCS 61 PROTEGE 61 TELINTRA R 61 GAMMAGARD 61 bevacizumab Avastin ® 61 induced macular edema 61 REG1 61 DUROS 61 oral nucleoside analogue 61 Delivery System NTDDS 61 erlotinib Tarceva ® 61 Initiate Clinical Trial 61 TAXUS Element Paclitaxel Eluting 61 somatostatin analogue 61 Opterone R 61 vinorelbine tartrate 61 urethral bulking agent 61 TRAIL receptor antibodies 61 Cleviprex TM clevidipine 61 Evoltra ® 61 transthyretin mediated amyloidosis ATTR 61 Entereg R 61 Kit CD# positive 61 ularitide 61 dihydrochloride Tablets 61 Tezampanel 61 Wafer polifeprosan 61 opioid induced bowel dysfunction 61 PATHFINDER ® 61 DU #b 61 JAK inhibitor 61 dependent kinase inhibitor 61 Panzem R 61 Phase III Pivotal 61 rALLy clinical trial 61 intranasal formulation 61 endoluminal stent graft 61 Clinical Trial Evaluating 61 novel oral anticoagulant 61 trial evaluating PRX# 61 Nerve Targeting Drug 61 mecarbil 61 Methylnaltrexone 61 clot retrieval 61 fosbretabulin 61 castrate resistant prostate cancer 61 TRIOLEX ™ 61 Parkinson disease levodopa induced 61 VBLOC ® 61 Veronate R 61 sapropterin dihydrochloride Tablets 61 LEVADEX TM 61 HepeX B TM 61 rusalatide acetate 61 Altera Nebulizer System 61 Soliris eculizumab 61 coronary carotid 61 SEPET TM 61 THR beta agonist 61 octreotide implant 61 Annamycin 61 FOLFOX6 chemotherapy regimen 61 Orally administered 61 cannabinor 61 IAP inhibitor 61 Exherin TM 61 Nektar proprietary 60 SCH # 60 JAK2 Inhibitor 60 IL# PE#QQR 60 Anturol TM 60 HuMax Wnt 60 drug ISA# 60 pain palliation 60 DCVax R 60 familial amyloidotic polyneuropathy FAP 60 Sapacitabine 60 TM Aganocide 60 retinal vein occlusion induced 60 Bone Graft 60 Pivotal Phase III 60 rxRNA 60 hormone LHRH antagonist 60 patented Bioral 60 Completes Patient Enrollment 60 Ridaforolimus 60 sd rxRNA 60 unique alkylating agent 60 sapacitabine CYC# 60 PATHFINDER R 60 PROVENGE ® 60 CBLC# 60 Crofelemer budesonide foam 60 Vascugel ® 60 AzaSite Xtra 60 receptor tyrosine kinase inhibitor 60 investigational monoclonal antibody 60 PNP inhibitor 60 Golimumab 60 Phase 2a Clinical Trial 60 Achieves Primary Endpoint 60 Zorbtive TM 60 developing Bicifadine serotonin 60 Cetrorelix 60 ocular formulation 60 VBLOC R 60 OMNARIS HFA 60 lucinactant 60 AAG geldanamycin analog 60 mechanical thrombectomy 60 PDX pralatrexate 60 Acute Ischemic Stroke 60 Perceiva 60 cetrorelix pamoate 60 SUTENT ® 60 alfimeprase direct 60 SABER ™ 60 MEK inhibitors 60 hyaluronidase enzyme 60 TNF Tumor Necrosis Factor 60 IMA# 60 Intravitreal injections 60 sorafenib tablets 60 AzaSite Plus 60 candidate XP# 60 Pivotal Study 60 Vascugel 60 fallopian tube cancers 60 samarium Sm 60 iobenguane 60 Vicinium TM 60 INCB# [001] 60 Iluvien TM 60 PMX # antibiotic 60 R sorafenib tablets 60 SAR# [002] 60 Telik logo TELINTRA 60 BrachySil TM 60 INTEGRILIN R 60 sapropterin dihydrochloride 60 opioid naive 60 dasatinib Sprycel ® 60 aripiprazole Abilify 60 Phase IIa trials 60 Prostate AdenoCarcinoma Treatment 60 R lenalidomide 60 Rescula 60 SNT MC# 60 virus HCV protease inhibitor 60 TAFA# 60 Safinamide 60 Alair System 60 Phase 2b Clinical Trial 60 essential thrombocythemia ET 60 leading oral taxane 60 Phase 2b clinical trials 60 dirucotide MBP# 60 Novolimus 60 Electronic Brachytherapy System 60 post herpetic neuralgia PHN 60 ALN TTR# 60 CB2 selective receptor agonist 60 Liposomal 60 Demonstrates Positive 60 Phase IIB 60 Phase 1b clinical trials 60 deCODE AF TM 60 erlotinib Tarceva R 60 targeted antifolate 60 5 HT3 antagonist 60 investigational pan BCR 60 cardiac myosin activator omecamtiv 60 Receives Orphan Drug Designation 60 Pivotal Phase 60 Patients Treated With 60 Prestara TM 60 GED aPC 60 Study Evaluating 60 chronic myocardial ischemia 60 cIAI 60 Dalbavancin 60 CCX# 60 NDA Submission 60 albiglutide 60 proprietary transdermal 59 anti angiogenic agents 59 phase IIa clinical 59 Initiates Clinical 59 CTAP# Capsules 59 diabetic macular edema DME 59 BCG refractory carcinoma 59 Kuvan TM sapropterin 59 Traficet EN 59 Zemiva TM 59 docetaxel Taxotere R 59 Clolar ® 59 bifurcation stent 59 investigational pharmacologically unique 59 Cardium Therapeutics TM 59 undergoing elective percutaneous 59 Capesaris 59 PEGylated anti 59 Xcelerant Delivery System 59 cisplatin gemcitabine 59 CINQUIL 59 recurrent glioblastoma 59 pseudobulbar affect PBA 59 Locteron ® 59 recombinant tissue plasminogen 59 NeoLipid R 59 tartrate Inhalation Solution 59 SPL# Gel vaginal microbicide 59 pralatrexate injection folate analogue 59 Genasense ® oblimersen 59 non alcoholic steatohepatitis 59 Curaxin CBLC# 59 apomorphine hydrochloride 59 Panzem R NCD 59 Cloretazine VNP#M 59 Aflibercept 59 selective A2A adenosine receptor 59 QUADRAMET R 59 ulimorelin 59 Ceflatonin R 59 small molecule glucokinase 59 nilotinib Tasigna ® 59 Aryplase 59 cilengitide 59 Injectable Bone Graft 59 Oracea TM 59 methylnaltrexone bromide 59 AFREZZA TM 59 SUPPRELIN R LA 59 diarrhea predominant irritable 59 inhalation aerosol 59 p# inhibitor 59 Adnectin 59 descending thoracic 59 metastatic neuroendocrine tumors 59 cetuximab Erbitux ® 59 immunotherapeutic agent 59 thalidomide Thalomid 59 Tengion Neo Bladder Augment 59 R#/MEM # 59 TRIOLEX HE# APOPTONE HE# 59 BrachySil 59 postoperative ileus POI 59 Luveris R Ovidrel R 59 tezampanel NGX# 59 MKC# 59 clinical trials Archexin ® 59 telomerase therapeutic 59 PORxin TM 59 Aurexis R 59 Fx #A 59 Phase 1b Clinical Trial 59 Initiated Phase 59 cell lymphoma CTCL 59 Vidaza azacitidine 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 SonoLysis 59 Surfaxin LS 59 Fibrillex TM 59 Phase IIIb 59 visilizumab 59 NUVIGIL ® 59 Fibromyalgia Syndrome FMS 59 Levacor TM 59 MEND CABG 59 trastuzumab DM1 T DM1 59 occlusion CRVO 59 Proxinium TM 59 SYN# 59 Phase #b/#a trial 59 2 methoxyestradiol 59 Bayer HealthCare Onyx Pharmaceuticals 59 ™ pralatrexate injection 59 pan histone deacetylase 59 INSPIRE Trial Phase III 59 tizanidine hydrochloride short 59 mGluR2 positive 59 OncoVEX GM CSF 59 dextofisopam 59 Fludara ® 59 myocardial infarction ventricular fibrillation 59 superficial femoral 59 5 fluorouracil leucovorin 59 coronary stent merged 59 Xcytrin R 59 LUVENIQ 59 LEP ETU 59 XL# XL# 59 Embolic Protection 59 PrevOnco ™ 59 Bioral ® 59 Pharmacokinetics PK 59 Files IND 59 Begins Dosing 59 retinal disorders 59 Disease IBD 59 MEK Inhibitor 59 dilated cardiomyopathy DCM 59 Pharmos pipeline 59 paclitaxel poliglumex 59 PrevOnco 59 candidate AQ4N 59 novel synthetic peptide 59 IMiDs 59 oncolytic virus therapies 59 Alocrest 59 STARFlex R 59 oral beclomethasone dipropionate 59 rhIGF-I/rhIGFBP-3 59 Augment ™ 59 TAXUS TM 59 oral rivaroxaban 59 induced mucositis 59 inhaled formulation 59 sarcoma melanoma 59 refractory chronic lymphocytic 59 overactive bladder AA# 59 Prochymal TM 59 Nebulizer System 59 Bucindolol 59 diarrhea fatigue asthenia 59 LymphoStat B belimumab 59 Investigational Oral 59 squalamine 59 ILUVIEN ® 59 Pegasys ® 59 ATRA IV 59 successfully commercialize Iluvien 59 vinca alkaloid 59 DDP# 59 Européenne Mark 59 registrational Phase 59 YONDELIS 59 unresectable recurrent 59 Ovitrelle R Serostim 59 CCR9 antagonist 59 myelodysplastic myeloproliferative diseases 59 pan HDAC inhibitor 59 PHASE III 59 EyeGate ® II 59 visit www.dobimedical.com 59 systemic juvenile idiopathic 59 CIMZIA R 59 intravesical infusion therapy 58 aflibercept VEGF Trap 58 custirsen 58 HuMax EGFr 58 Modrenal R 58 ambulatory infusion pumps 58 Indaflex TM 58 FASLODEX 58 hypervascular tumors 58 Squalamine 58 intravenous methylnaltrexone 58 DEEP AF 58 CRMD# 58 MYDICAR ® 58 subcutaneous formulation 58 Mipomersen 58 forodesine 58 toenail onychomycosis 58 Selzentry Celsentri 58 include PLX IBD 58 treat refractory angina 58 percutaneous aortic valve 58 introduced NEUGENE 58 Pegloticase 58 Iluvien ® 58 evaluating picoplatin 58 ALGRX 58 PRT# 58 Daclizumab 58 CINTREDEKIN BESUDOTOX 58 huC# DM4 58 Company TAIFUN R 58 MEK inhibitor RDEA# 58 NovaBay Aganocide compounds 58 PresbyLens ® 58 hypereosinophilic syndrome 58 ALN HPN 58 Regenerative Cells 58 anticancer compound 58 SUMAVEL 58 monoclonal antibody IgG1 Mab 58 Percutaneous Transluminal Coronary Angioplasty 58 neovascular diseases 58 Savella ® 58 GALNS 58 vaccines oncolytic virus 58 omega interferon 58 Phase Ib study 58 Neo Bladder Augment 58 Androxal TM 58 non nucleoside 58 alpha interferons 58 cardiac resynchronisation therapy 58 antiangiogenesis therapies 58 PEG uricase 58 PHX# 58 Rilonacept 58 Genasense ® 58 OMS#HP 58 synthetic retinoid 58 Prospective Randomized 58 Chemophase 58 TO AVOID PREGNANCY WHILE 58 tezampanel 58 vaginally administered lidocaine 58 liver resection surgeries 58 alfa 2a 58 Prodarsan R 58 Central Retinal Vein 58 aerosolized KL4 surfactant 58 EGFR HER2 58 Commences Phase 58 ospemifene 58 RhuDex 58 XL# XL# XL# XL# 58 accumulate preferentially 58 OmniWave 58 Testosterone MDTS ® 58 occlusive disease 58 immuno inflammatory diseases 58 Dupuytren Disease 58 GEM OS1 58 AKT inhibitor 58 recombinant adeno associated 58 Dose Ranging Study 58 placebo controlled clinical 58 riociguat 58 Onalta ™ 58 PEGylated Fab fragment 58 Oral Fingolimod 58 Investigational Treatment 58 Generx ® 58 evaluating tivozanib 58 PEGylated interferon 58 VEGFR2 inhibitor 58 drug eluting stent DES 58 Lixivaptan 58 humanized anti 58 dosage regimens 58 Tasimelteon 58 Granted Orphan Drug 58 Phase IIb Clinical Trial 58 Tectin TM 58 LibiGel ® 58 systemic anaplastic large 58 BR.# 58 post operative ileus 58 phenylketonuria PKU developed 58 ATL# [001] 58 INCB# [003] 58 includes TOLAMBA TM 58 Valiant Thoracic Stent Graft 58 Tesetaxel 58 refractory angina 58 Augment Injectable Bone Graft 58 immunomodulatory therapy 58 Gel Delivery 58 GATTEX ® 58 EXPAREL TM 58 Enkephalin 58 MCSP respectively 58 immunological diseases 58 Pimavanserin 58 Vascular Disrupting Agent 58 REVLIMID lenalidomide 58 chemosaturation 58 STELARA TM 58 oropharyngeal candidiasis OPC 58 Complicated Skin 58 Retisert ® 58 ADP receptor antagonist 58 Hepatocellular Carcinoma HCC 58 Carotid 58 herpetic keratitis 58 R roscovitine CDK cyclin 58 Simulect 58 Peyronie Disease 58 NEBIDO R 58 Troxatyl 58 use transdermal sumatriptan 58 TELCYTA 58 markets HP Acthar 58 selective androgen receptor modulator 58 mertansine 58 Eraxis 58 trastuzumab Herceptin R 58 arthritis PsA 58 RapidBlue TM 58 metastatic castration resistant 58 INS# [001] 58 inhibitor PPI 58 systemically administered 58 WallFlex Biliary RX 58 PGL# 58 Biliary System 58 antibody MAb 58 MIRAPEX ER 58 RGB # 58 OMAPRO ™ 58 Exelixis compounds 58 PORxin TM platforms 58 chronic thromboembolic pulmonary 58 SPRYCEL ® 58 double blinded placebo 58 Tolvaptan 58 Initiates Phase III 58 refractory gout 58 Plasmin 58 Plicera 58 Testosterone MDTS R 58 EchoCRT 58 Drug Eluting Stent System 58 Vicriviroc 58 Microwave Ablation System 58 Ketotransdel TM 58 ATD TM gel 58 Aerosurf 58 patients undergoing percutaneous 58 R#/MEM 58 Genasense R 58 Afatinib 58 IN.PACT Falcon 58 bevacizumab Avastin R 58 immunotherapeutic vaccine 58 Diabetic Macular Edema DME 58 Embolic Protection Device 58 dextromethorphan quinidine 58 Transdermal Patch 58 VELCADE melphalan 58 Gabapentin GR 58 prophylactic therapy 58 Preclinical studies suggest 58 orally inhaled 58 Vidaza R 58 AEG# 58 XmAb 58 Azedra ™ 58 phenylalanine ammonia lyase 58 Warner Chilcott Actonel 58 DG# compounds targeting 58 Chrysalin 58 Ketotransdel 58 Xcellerated T Cells 58 Merci Retrieval System 58 LHRH antagonists 58 Hedgehog Pathway Inhibitor 58 HDAC Inhibitor 58 Octreolin 58 MAGE A3 ASCI 57 Pericardial 57 Trobalt 57 HepeX B 57 pioglitazone HCl 57 Stedivaze 57 Loceryl ® 57 systemic fungal infections 57 psoriasis rheumatoid arthritis 57 Dementia Related Psychosis 57 ImmunoBody ® 57 peripheral arterial occlusive disease 57 Deforolimus 57 replacement PAVR 57 HuMax TAC 57 LEVAQUIN ® 57 potent CYP#A# inhibitors 57 novel emulsion formulation 57 pertuzumab 57 6R BH4 57 investigational humanized monoclonal antibody 57 metastatic castrate resistant 57 Zenvia ™ 57 Catena ® 57 Veronate 57 Belimumab 57 Serdaxin ® 57 Adhesion Barrier 57 Stent System 57 topical gel formulation 57 proprietary transdermal patch 57 ACTEMRA TM 57 thiazolides 57 Phase IIIb clinical 57 lenalidomide Revlimid R 57 thoracoscopic lobectomy 57 AS# amonafide L malate 57 Collategene 57 Initiate Phase II 57 severe hypercholesterolemia 57 Romiplostim 57 painful diabetic neuropathy 57 DEB# 57 By JENNIFER LEARN 57 Randomized Phase 57 non nucleoside inhibitor 57 relapsed refractory multiple myeloma 57 Romidepsin 57 candidate Zenvia 57 anionic backbone 57 HCV NS5B polymerase 57 European Sepsis Trial 57 Proellex TM 57 aortic stent grafts 57 ALVESCO HFA 57 placebo controlled Phase 57 Besivance 57 omecamtiv mecarbil 57 gastrointestinal mucositis 57 CorVue ™ 57 Abbokinase 57 treat benign prostatic 57 ThermoDox R 57 IMiDs ® 57 severe gastroparesis 57 Initiates Clinical Trials 57 preclinical efficacy 57 pegylated interferon alfa 2a 57 Inhalation Solution 57 Ecallantide 57 Vidaza ® 57 Bepreve TM 57 neratinib 57 Oral NKTR 57 CYP#A# CYP#D# 57 Atripla combines 57 relapsing multiple sclerosis 57 investigational HCV polymerase 57 class mGluR5 inhibitor 57 Phase 2a clinical trials 57 recurrent NSCLC 57 Calcitonin 57 CTA# Injection 57 GATTEX ™ 57 Rhucin ® recombinant 57 Randomized Double blind 57 Sufentanil 57 pharmacokinetic PK study 57 nucleoside analog 57 OvaRex ® MAb 57 EDEMA3 trial 57 IMPACT IMmunotherapy 57 PARI Pharma GmbH 57 lanreotide 57 Vascular Grafts 57 Dural Regeneration Matrix 57 serotonergic drugs 57 EXPLORE Xa 57 Solzira TM 57 IMiDs R 57 BYETTA ® 57 CORLUX CORT # 57 vaginal candidiasis 57 dasatinib Sprycel 57 Pirfenidone 57 HCV protease inhibitor 57 Generx TM 57 OMS# 57 Trial Evaluating 57 relapsed MM 57 placebo controlled Phase III 57 Liprotamase 57 Fibrin Patch 57 oral ridaforolimus 57 ® bortezomib 57 Kuvan R 57 nosocomial pneumonia 57 novel histone deacetylase 57 functional mitral regurgitation 57 ATS Simulus R 57 Exherin 57 mu opioid receptor antagonist 57 AERx ® 57 Orphan Drug status 57 oral deforolimus 57 Phase Ib clinical 57 oral dual endothelin 57 IPLEX 57 First Patient Enrolled 57 PDE4 inhibitor 57 investigational therapies 57 NeuroFlo 57 tiuxetan 57 GORE TAG Device 57 nasal calcitonin product 57 sorafenib Nexavar 57 next generation URAT1 57 UPLYSO 57 acute PAO 57 NOTE POSIDUR ™ 57 Phase Ib II 57 JAK1 57 Solution XOPENEX HFA 57 Surgical Sealant 57 highly selective endothelin 57 CRLX# 57 diabetic neuropathic pain 57 IONSYS TM 57 Bioral 57 rALLy 57 OnDose TM 57 Tyrosine Kinase Inhibitor 57 generation DACH Platinum 57 Allovectin 7 r 57 topiramate Topamax 57 Advanced Renal Cell 57 Nanobody 57 MGN# 57 Proquin XR 57 sublingual tablets 57 PEGINTRON TM 57 syndrome overactive bladder 57 Phase Ib IIa 57 somatostatin analog 57 Phase 1a clinical 57 IIa Clinical Trial 57 acne impetigo 57 ONCONASE R 57 ORENCIA ® 57 r hGH 57 Dyloject TM 57 anti infective treatments 57 evaluating mipomersen 57 alvimopan 57 QuadraSphere 57 OSMOPREP 57 Aridol TM 57 Xeloda ® 57 Acute Attacks 57 AzaSite ISV 57 cancer neuroendocrine tumor 57 lidocaine hydrochloride monohydrate powder 57 Triapine 57 N acetylgalactosamine 6 57 ACAPODENE 57 carcinoid syndrome 57 Sym# 57 IMPACT DCM 57 DAPT 57 LE SN# 57 Cloretazine 57 hyperphenylalaninemia HPA due 57 IgG1 monoclonal antibody 57 MyoSure 57 Lucanix R 57 HGS# 57 neovascular form 57 anastomotic devices 57 Mg Usa 57 IMPACT DCM trial 57 EGS# 57 tumor lysis syndrome 57 evaluating satraplatin 57 First Patient Dosed 57 small molecule activators 57 extracorporeal circulatory support 57 metformin HCl 57 hyperplasia BPH 57 VIAtab TM 57 Dacetuzumab 57 ciprofloxacin hydrochloride 57 GTC recombinant human 57 Plaque Psoriasis 57 LPM TM 57 6 sulfatase 57 sodium Injection 57 PDE4 inhibitors 57 PLK1 SNALP 57 NGX# 57 Warfarin Coumadin 57 Imprime PGG 57 Endovascular System 57 Oxiplex 57 R Perfexion TM 57 pharmacogenomic translational research 57 clinical trials SGN 57 Prodarsan ® 57 davunetide intranasal AL 57 automated radiopharmaceutical distribution 57 fibrotic disease 57 FDA Approvals 57 baminercept 57 Phase III multicenter 57 phase IIa 57 primary hypercholesterolemia 57 Aggrastat ® tirofiban hydrochloride 57 lamotrigine Lamictal 57 HeartMate ® 57 thetreatment 57 noninfectious uveitis 57 embolic protection device 57 Phase III Trial 57 INFUSE ® 57 sNDA submission 57 Liprostin 57 repair TEVAR 57 unstable angina UA 57 Receives Orphan Drug 57 Fibrin Pad 57 ribavirin RBV 57 Efficacy Trial 57 atypical Hemolytic Uremic Syndrome 57 Interferon beta 57 central retinal vein 57 Carfilzomib 57 imetelstat GRN#L 57 EVIZON TM 57 Lauriad 57 SomatoKine 57 LEVAQUIN 57 LUNESTA ® 57 sunitinib Sutent ® 57 neuro vascular 57 Degarelix 57 Phase IIb III 57 Aplidin R 57 Phase Ib 57 AQ4N 57 Cinryze TM 57 multicenter Phase II 57 OAB overactive bladder 57 catheters guidewires 57 CEQ# 57 OX1 57 Benign Prostatic Hyperplasia BPH 56 torsemide ER 56 HGS ETR1 56 TACI Ig 56 BiovaxID TM 56 CoreValve System 56 human C1 inhibitor 56 punctal plug delivery 56 BRAF inhibitor 56 drug eluting balloons 56 omecamtiv mecarbil formerly 56 Alseres Cethrin 56 VAPRISOL 56 budesonide foam 56 HCD# [002] 56 Patient Enrollment 56 neurogenic bladder 56 HuCAL PLATINUM ® CysDisplay 56 REPRONEX R menotropins 56 RoACTEMRA 56 signal detection CTSD 56 ZOLINZA 56 RESTORE CLI trial 56 Ophena TM 56 solid organ transplantation 56 demonstrated antitumor activity 56 basal bolus regimen 56 nephropathic cystinosis 56 VISICOL R 56 Excellarate TM 56 Optiquel ™ 56 Allovectin 7 56 investigational antiplatelet agent 56 delipidation 56 Dapagliflozin